glp-1 patent Medicines Pool Executive Director Charles Gore tells Devex that one of his priorities in his last year on the job is to get a license for therapies. But he admits pharmaindustry #glp1 #patentcliff #obesitytreatment #diabetescare

Light sensitivity so intense you need to lie in a dark room

This evolving landscape highlights the growing importance of innovation and patent strategies in shaping the future of weight loss and obesity treatments

If youve been watching the news (or your newsfeed) lately, you might have heard about the new pharmaceutical phenomenon sweeping the nation: a diabetes drug for weight loss

Tirzepatide activates GIP and GLP-1 receptors in the exocrine pancreas, promoting a reduction in blood glucose levels and aiding in the management of type 2 diabetes (T2D) [1]

Diabetes 54 , 22122218 (2005)

When taken correctly with strict adherence to the sublingual protocol, GLP-1 drops are designed to be therapeutically equivalent